BCRX
Price
$8.15
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
6 days until earnings call
NKTX
Price
$3.46
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
8 days until earnings call
Ad is loading...

BCRX vs NKTX

Header iconBCRX vs NKTX Comparison
Open Charts BCRX vs NKTXBanner chart's image
BioCryst Pharmaceuticals
Price$8.15
Change-$0.00 (-0.00%)
Volume$1.48M
CapitalizationN/A
Nkarta
Price$3.46
Change-$0.00 (-0.00%)
Volume$1.33M
CapitalizationN/A
View a ticker or compare two or three
BCRX vs NKTX Comparison Chart
Loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BCRX vs. NKTX commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCRX is a StrongBuy and NKTX is a StrongBuy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (BCRX: $8.11 vs. NKTX: $3.41)
Brand notoriety: BCRX: Notable vs. NKTX: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCRX: 56% vs. NKTX: 193%
Market capitalization -- BCRX: $1.58B vs. NKTX: $318.22M
BCRX [@Biotechnology] is valued at $1.58B. NKTX’s [@Biotechnology] market capitalization is $318.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCRX’s FA Score shows that 1 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • BCRX’s FA Score: 1 green, 4 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, BCRX is a better buy in the long-term than NKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCRX’s TA Score shows that 5 TA indicator(s) are bullish while NKTX’s TA Score has 4 bullish TA indicator(s).

  • BCRX’s TA Score: 5 bullish, 5 bearish.
  • NKTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both BCRX and NKTX are a good buy in the short-term.

Price Growth

BCRX (@Biotechnology) experienced а +2.01% price change this week, while NKTX (@Biotechnology) price change was -18.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

BCRX is expected to report earnings on Feb 19, 2025.

NKTX is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCRX($1.58B) has a higher market cap than NKTX($318M). BCRX YTD gains are higher at: 36.060 vs. NKTX (-47.576). BCRX has higher annual earnings (EBITDA): -43.86M vs. NKTX (-115.21M). NKTX has more cash in the bank: 325M vs. BCRX (272M). NKTX has less debt than BCRX: NKTX (85.6M) vs BCRX (822M). BCRX has higher revenues than NKTX: BCRX (382M) vs NKTX (0).
BCRXNKTXBCRX / NKTX
Capitalization1.58B318M496%
EBITDA-43.86M-115.21M38%
Gain YTD36.060-47.576-76%
P/E RatioN/AN/A-
Revenue382M0-
Total Cash272M325M84%
Total Debt822M85.6M960%
FUNDAMENTALS RATINGS
BCRX: Fundamental Ratings
BCRX
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCRXNKTX
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 14 days ago
85%
Declines
ODDS (%)
Bearish Trend 22 days ago
80%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

BCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCRX has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BCRX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCRX
1D Price
Change %
BCRX100%
+2.52%
VCYT - BCRX
46%
Loosely correlated
+3.30%
NKTX - BCRX
46%
Loosely correlated
+3.90%
DNLI - BCRX
44%
Loosely correlated
+6.27%
PGEN - BCRX
43%
Loosely correlated
-0.61%
NTLA - BCRX
43%
Loosely correlated
+2.45%
More

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with FATE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
+3.90%
FATE - NKTX
49%
Loosely correlated
+8.30%
PGEN - NKTX
48%
Loosely correlated
-0.61%
BCRX - NKTX
46%
Loosely correlated
+2.52%
ALLO - NKTX
46%
Loosely correlated
+9.84%
CRBU - NKTX
46%
Loosely correlated
+6.21%
More